Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved rapidly, leading to viral lineages characterized by multiple mutations in the spike protein, which could potentially confer to the virus the ability to avoid the vaccine-induced immune response, making the vaccines less effecti...
Main Authors: | Fabrizia Valleriani, Elisa Mancuso, Giacomo Vincifori, Liana Teodori, Lisa Di Marcantonio, Massimo Spedicato, Alessandra Leone, Giovanni Savini, Daniela Morelli, Barbara Bonfini, Alessio Lorusso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/10/2011 |
Similar Items
-
Analysis of the Delta Variant B.1.617.2 COVID-19
by: Shayan Shiehzadegan, et al.
Published: (2021-10-01) -
Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant
by: Ionuț Isaia Jeican, et al.
Published: (2023-01-01) -
Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China
by: Qianyun Liu, et al.
Published: (2022-01-01) -
Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019
by: Chuanjun Xu, et al.
Published: (2022-12-01) -
BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients
by: Michal Herman-Edelstein, et al.
Published: (2022-06-01)